Clinical Trial Update: Quad Shot Radiotherapy in Combination With Immune Checkpoint Inhibition [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating quad-shot radiotherapy in combination with an immune checkpoint inhibitor for advanced and recurrent head and neck squamous cell carcin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Squamous Cell Carcinoma of the Head and Neck
• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Immune checkpoint inhibitor
• Quad Shot radiotherapy

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Advanced Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2025-11-19